ABSTRACT: Double chamber plethysmography is a well established noninvasive method of assessing airflow obstruction in small lab animals. It allows measurement of the specific airway resistance (sRaw), which unlike Penh, is a meaningful airway mechanics parameter. Since sRaw is measured in spontaneously breathing mice, a limitation of the method is the inability to exclude nasal resistance changes. We have recently shown that mice are not truly obligate nasal breathers, and that after nasal occlusion, nasally breathing mice can transition to an oral mode of breathing. We now show that it is experimentally possible to algebraically separate the average nasal and pulmonary (including laryngeal) components of total airway resistance change, by a series of measurements made across groups of mice breathing nasally or orally, assuming that oral resistance remains constant. Utilizing this approach, we show that nasal resistance change comprises half or more of the total resistance change during methacholine challenge. Inhibition of mucin secretion from airway goblet cells, attenuates pulmonary but not nasal airway hyperresponsiveness (AHR), and that nasal AHR in a murine model of rhinitis may be related to edema.
INTRODUCTION
An ideal method to determine airflow obstruction in mice would be reproducible, non-invasive, performed under physiological conditions, and provide physiologically meaningful output. The Bates uncertainty principle elegantly discusses why this does not seem possible (7). At one extreme lies simple unrestrained plethysmography with its often -criticized output, and Penh,which is difficult to relate to any physiological meaning (11), while at the other end lies the forced oscillation technique, which requires invasive measurements in anesthetized and mechanically ventilated mice (6). A useful middle is restrained plethsmography in spontaneously breathing mice, based on either Pennock's (14) or Agrawal's method (5) . Both methods provide a framework for measurement of sRaw in nasally breathing animals, where sRaw equals the product of thoracic gas volume (TGV) and airway resistance (Raw). A limitation of these methods is their inability to separately assess the pulmonary airway resistance that is considerably smaller than the total resistance. We took advantage of the fact that mice transition to an oral mode of breathing after nasal occlusion (4) to address this limitation. Assuming the oral resistance to be relatively constant during methacholine challenge, and lung volume to be similar before and after nasal occlusion, the change in sRaw in orally breathing mice (∆sRaw nose closed ) is proportional to the change in pulmonary airway resistance (∆Raw pulmonary ). Similarly, in nasally breathing mice, ∆sRaw nose open is proportional to the change in the total airway resistance (∆Raw pulm + ∆Raw nasal ). The values of ∆Raw in each case can be approximated by division by the normal thoracic gas volume at functional residual capacity (TGV FRC ) (0.5 ml). The use of a constant value for thoracic gas volume during induced constriction to estimate the absolute values for airway resistance will introduce a significant error which will increase as airway narrowing increases in severity. Since TGV FRC increases during methacholine challenge in spontaneously breathing mice (10), the derived ∆Raw, as used by us, is equivalent to actual ∆Raw normalized to baseline functional residual capacity. Given two successive measurements of sRaw (sRaw 1 =Raw 1 x TGV 1 ; sRaw 2 =Raw 2 x TGV 2 ), ∆Raw as calculated by us equals (Raw 2 x (TGV 2 /TGV 1 )) -Raw 1 , rather than Raw 2 -Raw 1 . This compensates for the effect of increase in TGV FRC that offsets airway narrowing by other mechanisms.
For example, if a spontaneously breathing mouse with baseline Raw of 0.5 ml/s/cm H 2 O developed airway obstruction compensated by hyperinflation such that the TGV FRC doubled from 0.5 ml to 1 ml, Raw remained nearly constant (similar to that reported by Lai-Fook et al, ref 10), and sRaw doubled, the directly measured ∆Raw would be near zero, while ∆Raw as derived by us would be 0.5 ml/s/cm H 2 O. Thus, for detection of airway obstruction, the use of sRaw derived Raw is a valid and useful measure in spontaneously breathing mice. Also, because the same error in estimating ∆Raw would occur when mice breathe with their nose patent and with their nose closed, this error would not affect the partition of Raw into nasal and pulmonary Raw. It follows that when averaged across groups, the difference between ∆Raw nose open and ∆Raw nose closed will be equal to ∆Raw nose , thus allowing calculation of pulmonary resistance and nasal resistance changes in spontaneously breathing mice. We tested the utility of this approach in mice models of asthma and rhinitis and found it to be useful in understanding the mechanisms of airway obstruction in nasal and pulmonary airways.
METHODS
This study was conducted in conformity with the American Physiological Society's Guiding Principles in the Care and Use of Animals. Experimental protocols and study design were approved by the institutional review boards at the Institute of Genomic and Integrative Biology, New Delhi, India. BIO-110006, a MARCKS protein related peptide that inhibits mucin secretion, was provided by BioMarck Pharmaceuticals, USA (1).
Induction of AHR, experimental allergic rhinitis, experimental allergic asthma. The study was conducted using male, inbred, BALB/c mice (16-20 gm body weight) obtained from V.P. Chest Institute (New Delhi, India) mice breeding program that were between eight and twelve weeks in age. Mucous metaplasia and AHR was induced by weekly intraperitoneal injection of 20 µg ovalbumin (Ova) in 2.25 mg alum for four weeks followed by airway challenge with 3% Ova aerosol (Ova/Ova) within 30 days of the last sensitization. Reference mice were sensitized but, instead of challenge with aerosolized Ova, aerosolized saline was administered (Ova/Sal). In selected mice, allergic rhinitis was induced by daily intra-nasal administration of 20 µl of 3% Ova solution in normal saline (NS), to sensitized mice, for 7 days.
Quantification of airflow obstruction. Specific airway resistance (sRaw) was measured as the time lag between flows recorded from the head and thoracoabdominal chambers in consciously breathing, restrained mice, using the two-chambered body plethysmograph system devised by Buxco (PLY-3351, Biosystem XA software). Briefly, this equipment consists of two plastic cylinders used as the thoracoabdominal and head compartments that can be attached to one another with an orifice, such that the head and neck of a mouse can pass through but not its shoulders. Mice were acclimatized to being restrained in the plethysmograph during the sensitization and challenge phase. To measure sRaw, mice were placed in the thoracoabdominal chamber, maneuvered to pass their head through the orifice, and gently wedged between the orifice and a posterior piston. Before attaching the head chamber, a suitably cut latex sheet was passed snugly over the neck and interposed between the two chambers to ensure that the chambers would be airtight. Phase lag between the airflow signals recorded from the two chambers was approximated using the time lag at zero flow, and sRaw was calculated. Other parameters such as respiratory rate, and respiratory volumes were also recorded.
Experimental protocol. After the protocol for development of AHR was completed, mice were subjected to methacholine (MCh) challenge to cause airway smooth muscle contraction, mucin hypersecretion and airflow obstruction. Briefly, stained sections were converted to 10x digitized images. Using the ImageJ software, images representing the region of interest were split into constituent colors, and threshold was adjusted manually such that only pixels representing a positive stain were seen. The threshold was defined using a control slide from each batch of slides stained together and kept constant for all further measurements. Automated particle analysis was used to calculate the pixel area. Two sections per lung specimen and specimens from at least three different animals were used per group. All values were expressed as percentage of the mucin content of airways from mice with mucous metaplasia that had not been subjected to MCh challenge.
Statistical Analysis. Two tailed Students T-test were used to ascertain significance of difference of means. The threshold of significance was set at 0.05.
RESULTS
Mice are preferential but not obligate nasal breathers. After nasal occlusion, most mice switch to an oral mode of breathing with no apparent discomfort for experimental durations ranging from 15 to 30 min. For ethical considerations, mice showing discomfort by struggling were allowed to breathe naturally. This was seen on only four occasions out of more than forty recordings.
Nasal occlusion causes slower and deeper breathing. To determine whether
there was substantial alteration in the breathing pattern, that could influence measurement of sRaw, we compared the visual flow traces and objective respiratory parameters between nasally or orally breathing mice (Table 1) 
DISCUSSION
We describe a novel adaptation of restrained plethysmography that allows noninvasive distinction of pulmonary and nasal airflow resistance changes during spontaneous breathing. However, there are many limitations to this approach.
First, while changes in pulmonary airflow resistance are measured directly, changes in nasal airflow resistance can only be derived based on the difference between averaged measurements from (1) a group of mice breathing orally (i.e., a measurement of pulmonary resistance) and (2) a group of mice breathing nasally (i.e., a measurement of nasal and pulmonary resistance). It follows that the standard errors associated with algebraically determined change in nasal resistance would be larger and thus associated with poorer resolution for small changes. This implies that for adequately powered statistical comparisons of nasal resistance changes between groups, the sample size must be suitably high, and experimental conditions must be optimized. Second, in our experimental definition, the transition point between nasal and pulmonary airways is at a level above the larynx where the nasal airways join the oral cavity.
Changes in laryngeal resistance would be included in the pulmonary component.
Since this is also true for plethysmography in humans, this is not considered to be a major problem but would recommend caution during comparisons with studies where animals were intubated or tracheostomized. Third, the oral resistance that we assume to be constant is significantly greater than the nasal resistance, presumably due to the close apposition between the palate and epiglottis in rodents, and can be a potential source of error, although our own investigations suggest that it is relatively constant within the limits of our experimental protocol. Fourth, it is assumed that pulmonary airway resistance change and the thoracic gas volume would be equal for animals breathing nasally or orally. While it seems reasonable to assume that thoracic gas volume would be similar because nasal occlusion is unlikely to cause significant changes in FRC because of the unchanged static mechanics of the lung and chest wall, the small increase in tidal volume noted by us (0.035 ml) may introduce a small error. The use of sRaw derived Raw values, which are normalized to baseline FRC, would be expected to limit this error. The slower and deeper breathing associated with nasal occlusion may however significantly influence the MChinduced pulmonary airway obstruction (15) . Also, MCh effect may be different depending on the route of inhalation. However such effects are unlikely to be large because in a small subset of six mice challenged with MCh before or after nasal occlusion, no difference between the post-MCh sRaw was observed.
Lastly, nasal occlusion is not possible if nasal airflow is directly measured at the nostrils, as in Agrawal's loop method (3). Such a setup was recently described in mice (9) and appears to be easier to perform with less experimental variability, although it is not yet commercially available.
Using this approach, it was found that an increase in nasal resistance is an In summary, partitioning of nasal and pulmonary components of airflow obstruction during spontaneous breathing is feasible and useful in addressing questions related to the airway response mechanisms. 
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